Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.

Related Keywords

United States ,White House ,District Of Columbia ,Douglas Tsao ,Jill Biden ,Sabrina Martucci Johnson ,Mardee Haring Layton ,Nasdaq ,White House Initiative On Women Health Research ,White House Gender Policy Council ,Dare Bioscience Inc ,Bioscience Inc ,Development Agreement ,Call Transcript March ,Fourth Quarter Financial Results ,General Business ,Chief Executive Officer ,Chief Accounting ,Martucci Johnson ,Safe Harbor ,Private Securities Litigation Reform Act ,Sildenafil Cream ,White House Initiative ,Health Research ,First Lady ,History Month ,President Biden ,Chief Accounting Officer ,Dee Haring Layton ,Vice President ,Cooperative Research ,Declining States ,Lowest Homeless Population ,Dare Bioscience ,Will Hidell ,Brookline Capital ,